Skip to main content
. 2009 May;6(5):20–33.

Table 1.

Baseline characteristics of randomized patients.

TCOAD (N=202) PLACEBO (N=204) P VALUE
DEMOGRAPHICS
Gender (n) > 0.99
Male 73 (36.1%) 73 (35.8%)
Female 129 (63.9%) 131 (64.2%)
Age (years)
Mean (SD) 43.8 (12.8) 44.0 (13.5) 0.87
Ethnic origin (n) Caucasian: 139 (68.8%)
Black: 41 (20.3%)
Asian: 4 (2.0%)
Other: 18 (8.9%)
Caucasian: 140 (68.6%)
Black: 44 (21.6%)
Asian: 3 (1.5%)
Other: 17 (8.3%)
0.97
CLINICAL CHARACTERISTICS
HAMD-17 total score [mean (SD)] 23.2 (4.2) 22.4 (4.4) 0.08
MADRS total score [mean (SD)] 32.6 (4.1) 31.9 (4.3) 0.21
Clinical global impression,
severity of illness (n)
Mildly ill: 0
Moderately ill: 95 (47.0%)
Markedly ill: 104 (51.5%)
Severely ill: 3 (1.5%)
Mildly ill: 1 (0.5%)
Moderately ill: 115 (56.4%)
Markedly ill: 85 (41.7%)
Severely ill: 3 (1.5%)
0.13
Overall quality of sleep (n) Excellent: 2 (1.0%)
Good: 13 (6.4%)
Fair: 91 (45.0%)
Very poor: 96 (47.5%)
Excellent: 3 (1.5%)
Good: 17 (8.3%)
Fair: 85 (41.7%)
Very poor: 99 (48.5%)
0.8
Trouble falling asleep (n) Never: 15 (7.4%)
Rarely: 25 (12.4%)
Frequently: 98 (48.5%)
Always: 64 (31.7%)
Never: 18 (8.8%)
Rarely: 37 (18.1%)
Frequently: 90 (44.1%)
Always: 59 (28.9%)
0.37
Awakening during the night (n) Never: 6 (3.0%)
Rarely: 26 (12.9%)
Frequently: 90 (44.6%)
Always: 80 (39.6%)
Never: 6 (2.9%)
Rarely: 28 (13.7%)
Frequently: 90 (44.1%)
Always: 80 (39.2%)
> 0.99

TCOAD=Trazodone Contramid OAD